ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Other Events
Item 8.01. Other Events.
On January 28, 2019, Accuray Incorporated (the “Company”) issued a press release announcing that the Company’s wholly-owned subsidiary, Accuray Asia Limited (“Accuray Asia”), entered into an agreement with CNNC High Energy Equipment (Tianjin) Co., Ltd. (the “CIRC Subsidiary”), a wholly-owned subsidiary of China Isotope & Radiation Corporation, to form a joint venture to manufacture and sell radiation oncology systems in China.Accuray Asia will initially have a 49% ownership interest in the joint venture and the CIRC Subsidiary will initially have a 51% ownership interest in the joint venture.
A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
Press release dated January 28, 2019.
ACCURAY INC Exhibit
EX-99.1 2 aray-ex991_6.htm EX-99.1 aray-ex991_6.htm Exhibit 99.1 ACCURAY AND CHINA ISOTOPE AND RADIATION CORPORATION ENTER JOINT VENTURE CONTRACT TO MANUFACTURE AND SELL RADIATION ONCOLOGY SYSTEMS IN CHINA Joint Venture Uniquely Positioned to Serve World’s Largest Growth Market for Radiation Oncology Systems Conference Call Today at 6:00 a.m. PT/ 9:00 a.m. ET SUNNYVALE,…
To view the full exhibit click
About ACCURAY INCORPORATED (NASDAQ:ARAY)
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.